Month: September 2013
Biogen bets more on Isis technology for neurological drugs
By Deena Beasley (Reuters) – Biogen Idec has agreed to pay another $100 million upfront to Isis Pharmaceuticals Inc as part of a broad collaboration to develop new medicines for neurological disorders, the companies said on Monday. The news sent Isis's shares up 9 percent in premarket trade. The deal is the fourth between the companies in the last two years, and aims to use the "antisense" technology invented by Isis to accelerate discovery of drug targets for neurodegenerative diseases. …
Oncolytics lung cancer drug shrinks tumors in 92 percent of patients in trial
(Reuters) – Oncolytics Biotech Inc said its cancer drug Reolysin reduced the size of tumors in 92 percent of lung cancer patients in a mid-stage trial. The company’s shares rose as much as 22 percent to $3.22 in trading before the bell. The drug was tested on patients suffering from advanced squamous cell carcinoma of the lung. It was used intravenously in combination with chemotherapy drugs carboplatin and paclitaxel. …
Simulating the spread of disease
E-cigarettes are just as good as patches for quitting smoking: study
Groups race to hire, train ‘Obamacare’ guides
CHICAGO (AP) — With the program known as "Obamacare" only weeks away from its key launch date, hectic preparations are in motion in communities across the country to deal with one of its major practical challenges: hiring and training a small army of instant experts who can explain the intricacies of health insurance to people who've never had it.
Diet Doc Weight Loss Plans Introduces the Nation's Best Diet Pills …
Gluten-free diet depends on what ails you
Insight: Research renaissance offers new ways out of depression
By Kate Kelland, Health and Science Correspondent LONDON (Reuters)- As Susan sits chatting to a nurse in a London clinic, a light tapping sound by her head signals that parts of her brain are being zapped by thousands of tiny electro-magnetic pulses from a machine plugged into the wall. The 50 year-old doctor is among growing ranks of people with so-called treatment-resistant depression, and after 21 years fighting a disorder that destroyed her ability to work and at times made her want to "opt out of life", this is a last resort. …
Norway’s opposition set for sweeping election victory
By Balazs Koranyi OSLO (Reuters) – Norway's center-right opposition, pledging privatization, tax cuts and smaller government, was set for a sweeping election win on Monday but faces difficult coalition talks since a populist anti-immigration party will hold the balance of power. Norway has enjoyed rare economic success, thanks to its flourishing offshore oil sector boosting per capita GDP to $100,000. But growth is slowing and voters are ready to punish Labour Prime Minister Jens Stoltenberg, accusing him of wasting a once-in-a-lifetime economic boom. …